InvestorsHub Logo
icon url

Whalatane

11/25/19 3:54 PM

#230059 RE: sts66 #230055

STS. of course convenience of use doesn't matter at all ...correct ?

I mean who would want to give up self injecting Repatha every 2 wks ( which is what I do ) if they were offered the option of your MD giving you one shot at your annual physical ...and if timed right ...the second shot when you get your flu shot.

I know ..you would miss not having to self inject a drug every two weeks ...me ? Sign me up for Inclisiran biannual shots from an MD or PA

Its going to be an Inclinisran / Vascepa world for all those that do not like statins, can't get their LDL low enough on statins , forget to take their statins OR just drop the statin after 1 yr anyway ( 50% of those prescribed )
Kiwi
icon url

GD

11/25/19 4:20 PM

#230064 RE: sts66 #230055

You are under estimating Inclisiran peak sales, Repathas Q3 sales
grew 40% from last to $186M and I am sure will reach $1B sales next
year, Inclisiran is much better than Repatha, IMO.